Evidence map›Paper›PMID 37665998›Full record

ArticleAnnals of internal medicine2023

Comparative Safety Analysis of Oral Antipsychotics for In-Hospital Adverse Clinical Events in Older Adults After Major Surgery : A Nationwide Cohort Study.

Dae Hyun Kim, Su Been Lee, Chan Mi Park, Raisa Levin, Eran Metzger, Brian T Bateman, E Wesley Ely, Pratik P Pandharipande, Margaret A Pisani, Richard N Jones and 2 more

Open access · greenAbstract read
In one paragraph

Article in Annals of internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Dae Hyun KimDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston; Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston; Division of Gerontology, Beth Israel Deaconess Medical Center, Boston; and Harvard Medical School, Boston, Massachusetts (D.H.K.).ORCID 0000-0001-7290-6838
Su Been LeeDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts (S.B.L., R.L.).
Chan Mi ParkHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston; and Harvard Medical School, Boston, Massachusetts (C.M.P., E.M.).ORCID 0000-0003-1880-048X
Raisa LevinDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts (S.B.L., R.L.).
Eran MetzgerHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston; and Harvard Medical School, Boston, Massachusetts (C.M.P., E.M.).ORCID 0000-0002-7665-4540
Brian T BatemanDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, California (B.T.B.).
E Wesley ElyDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tennessee (E.W.E.).ORCID 0000-0003-3957-2172
Pratik P PandharipandeDivision of Anesthesiology Critical Care Medicine, Departments of Anesthesiology and Surgery, Vanderbilt University Medical Center, Nashville, Tennessee (P.P.P.).ORCID 0000-0002-1389-8580
Margaret A PisaniDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut (M.A.P.).
Richard N JonesDepartment of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island (R.N.J.).ORCID 0000-0002-1049-218X
Edward R MarcantonioDivision of Gerontology, Beth Israel Deaconess Medical Center, Boston; Harvard Medical School, Boston; and Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts (E.R.M.).ORCID 0000-0002-2911-4250
Sharon K InouyeHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston; Division of Gerontology, Beth Israel Deaconess Medical Center, Boston; and Harvard Medical School, Boston, Massachusetts (S.K.I.).
Brigham and Women's Hospital · USHarvard University · USVanderbilt University Medical Center · USBeth Israel Deaconess Medical Center · USBrown University · USStanford University · USYale University · US

Funding

The Role of Inflammation in the Pathophysiology of Delirium and its Associated Long-Term Cognitive DeclineP01AG031720 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI INOUYE, SHARON K. · 2010 to 2022
$26.7M
READI-SET-GO: Researching Efficient Approaches to Delirium Identification - Sustaining Effective Translation to create Gero-friendly OrganizationsR01AG030618 · NIA · PENNSYLVANIA STATE UNIVERSITY, THE · PI DONNA Marie FICK, EDWARD R MARCANTONIO · 2008 to 2026
$7.9M
Development and Validation of a Delirium Severity ToolkitR01AG044518 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI INOUYE, SHARON K., JONES, RICHARD N · 2014 to 2024
$7.3M
NIDUS III: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research inDeliriumR33AG071744 · NIA · JOHNS HOPKINS UNIVERSITY · PI John W. Devlin, Esther Seunghee Oh · 2021 to 2026
$4.7M
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making - Extension to ADRDR01AG071809 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI KIM, DAE HYUN · 2021 to 2025
$3.5M
Prospective Monitoring of Newly Approved Cardiovascular Drugs in Older Adults with FrailtyR01AG062713 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI KIM, DAE HYUN · 2019 to 2022
$2.8M
Mid-Career Mentoring Award for Patient-Oriented Research in AgingK24AG035075 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MARCANTONIO, EDWARD R · 2010 to 2021
$1.9M
Epidemiology and Risk of Antipsychotic Use in Hospitalized Elderly with DeliriumR01AG056368 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI KIM, DAE HYUN · 2018 to 2020
$1.8M
Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health OutcomesK24AG073527 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI Dae Hyun Kim · 2022 to 2026
$862k
NIA NIH HHS K24 AG035075NIA NIH HHS K24 AG073527NIA NIH HHS P01 AG031720NIA NIH HHS R01 AG030618NIA NIH HHS R01 AG044518NIA NIH HHS R01 AG056368NIA NIH HHS R01 AG062713NIA NIH HHS R01 AG071809NIA NIH HHS R33 AG071744
6 · The paper itself

Abstract

backgroundAntipsychotics are commonly used to manage postoperative delirium. Recent studies reported that haloperidol use has declined, and atypical antipsychotic use has increased over time.

objectiveTo compare the risk for in-hospital adverse events associated with oral haloperidol, olanzapine, quetiapine, and risperidone in older patients after major surgery.

designRetrospective cohort study.

settingU.S. hospitals in the Premier Healthcare Database. PATIENTS: 17 115 patients aged 65 years and older without psychiatric disorders who were prescribed an oral antipsychotic drug after major surgery from 2009 to 2018.

interventionsHaloperidol (≤4 mg on the day of initiation), olanzapine (≤10 mg), quetiapine (≤150 mg), and risperidone (≤4 mg). MEASUREMENTS: The risk ratios (RRs) for in-hospital death, cardiac arrhythmia events, pneumonia, and stroke or transient ischemic attack (TIA) were estimated after propensity score overlap weighting.

resultsThe weighted population had a mean age of 79.6 years, was 60.5% female, and had in-hospital death of 3.1%. Among the 4 antipsychotics, quetiapine was the most prescribed (53.0% of total exposure). There was no statistically significant difference in the risk for in-hospital death among patients treated with haloperidol (3.7%, reference group), olanzapine (2.8%; RR, 0.74 [95% CI, 0.42 to 1.27]), quetiapine (2.6%; RR, 0.70 [CI, 0.47 to 1.04]), and risperidone (3.3%; RR, 0.90 [CI, 0.53 to 1.41]). The risk for nonfatal clinical events ranged from 2.0% to 2.6% for a cardiac arrhythmia event, 4.2% to 4.6% for pneumonia, and 0.6% to 1.2% for stroke or TIA, with no statistically significant differences by treatment group. LIMITATION: Residual confounding by delirium severity; lack of untreated group; restriction to oral low-to-moderate dose treatment.

conclusionThese results suggest that atypical antipsychotics and haloperidol have similar rates of in-hospital adverse clinical events in older patients with postoperative delirium who receive an oral low-to-moderate dose antipsychotic drug. PRIMARY FUNDING SOURCE: National Institute on Aging.

Indexed as

Antipsychotic AgentsEmergence DeliriumIschemic Attack, TransientAgedCohort StudiesFemaleHaloperidolHospital MortalityHospitalsHumansMaleOlanzapineQuetiapine FumarateRetrospective StudiesRisperidoneAntipsychotic AgentsHaloperidolOlanzapineQuetiapine FumarateRisperidone

Identifiers

PMID37665998
PMCPMC10625498
OpenAlexW4386414791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.